c33 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
96
Structured Review
ATCC
c33
C33, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1137 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c33+a/C-33+A/bio_rxiv__64898__2026__04__13__718024-223-7-8
Average 96 stars, based on 1137 article reviews
C33, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1137 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c33+a/C-33+A/bio_rxiv__64898__2026__04__13__718024-223-7-8
Average 96 stars, based on 1137 article reviews
c33 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Cell Culture:Article Title: Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer Article Snippet: .. Article Title: Lactate-induced miR-7-5p/TRIM33 Reprograms Metabolic Flux to Suppress Tumor Growth and Viral Reactivation. Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. Article Title: Lipid reprogramming induced by the NNMT-ABCA1 axis enhanced membrane fluidity to promote endometrial cancer progression. Article Snippet: .. Cell lines and cell culture The human EC cell lines Ca-Ski, DoTc2, SiHa, and Isolation:Article Title: Lactate-induced miR-7-5p/TRIM33 Reprograms Metabolic Flux to Suppress Tumor Growth and Viral Reactivation. Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. |